Full text is available at the source.
Abstract
Recent innovations include simplified iboga analogs and real-time EEG biomarkers for individualized psilocybin dosing.
- Simplified iboga analogs may offer tunable polypharmacology.
- Real-time EEG biomarkers could help tailor psilocybin dosing to individual needs.
- Standardized harmine-DMT ratios are associated with high bioavailability.
- These advancements may contribute to the development of safer and more reliable psychedelic medicines.
Simplified